单位：[1]Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, Shenzhen Nanshan People’s Hospital and the 6th Aliated Hospital of Shenzhen University Health Science Center, Shenzhen, China,深圳市康宁医院深圳市南山区人民医院深圳医学信息中心[2]Department of Pain Management, Jinling Hospital, Nanjing, China,[3]Department of Pain Medicine, Institute of Anesthesiology and Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China,华中科技大学同济医学院附属协和医院[4]Department of Pain Management, Shandong Provincial Hospital Aliated to Shandong First Medical University, Jinan, China,[5]Department of Pain Management and Anesthesiology, The Second Xiangya Hospital, Central South University, Changsha, China,[6]Department of Pain Management and Anesthesiology, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China,[7]Department of Pain Medicine, The First Aliated Hospital of Zhengzhou University, Zhengzhou, China,[8]Department of Pain Management, The First Aliated Hospital of Soochow University, Suzhou, China,[9]Department of Pain Management, The State Key Clinical Specialty in Pain Medicine, The Second Aliated Hospital, Guangzhou Medical University, Guangzhou, China,[10]Department of Pain Management, Sanbo Brain Hospital Capital Medical University, Beijing, China,[11]The First Aliated Hospital, Zhejiang University School of Medicine, Hangzhou, China,[12]Department of Pain Medicine, Peking University People’s Hospital, Beijing, China,[13]Department of Pain Medicine, China-Japan Friendship Hospital, Beijing, China,[14]Department of Pain Medicine, The First Hospital, China Medical University, Shenyang, China,[15]People’s Hospital of Xinjiang Uyghur Autonomous Region, Ürümqi, China,[16]Department of Neurosurgery, Comprehensive Epilepsy Center, Sanbo Brain Hospital Capital Medical University, Beijing, China,[17]Department of Pain Management, The First Aliated Hospital, Jinan University, Guangzhou, China
Purpose: Short-term spinal cord stimulation (st-SCS) has been widely used to treat herpetic-related neuralgia (HN) in China for several years, but is stilt heavily debated as it has no strong evidence in clinical application. Therefore, a questionnaire survey among the Chinese pain specialist workgroup of the Chinese Neuromodulation Society and Chinese Medical Doctor Association was carried out to achieve a consensus about the clinical use of st-SCS for FIN treatment. Methods: The contents of the questionnaire include basic information about doctors (hospital level, work experience, training, procedure numbers, etc.), efficacy, indications, and contraindications of st-SCS, operation conditions, and preoperative preparation of st-SCS, and the prospect of the st-SCS procedure. Initially, the survey was conducted on 110 experts who have practiced the st-SCS procedure from alt over the provinces in China. Finally, valuable data was calculated from the 110 questionnaires excluding the doctors with <1 year of experience of st-SCS, <10 cases of procedures per year, and no standard training in SCS technique. Results: Based on the 110 questionnaires, it is estimated that 5,000 to 10,000 cases of electrical stimulation are carried out nationwide each year. Sixty-nine valid questionnaires acquired from senior pain physicians were more valuable and specialized in the efficacy, indications, and contraindications of st-SCS for HN. It was commonly agreed (97.10%) that the HN patients with <3 months will obtain good effectiveness (patient satisfaction rate >= 50%). Almost all (98.55%) agreed that st-SCS can be used in SHN patients, there was a common agreement (72.46%) that AHN patients are an indication of st-SCS, and more than half agreement (53.62%) that st-SCS may be fit for early PHN (3-6 months). A common agreement (79.71%) was achieved that more than half of HN patients had the experience of nerve block or nerve pulsed RF. A similarly large number of experts 57/69 (82.61%) agreed that an 80% paresthesia coverage should be achieved at the test stimulation and 57/69 (82.61%) agreed that the treatment of st-SCS need be persistent for 1-2 weeks. Conclusions: Early HN patients can get an effective outcome from the treatment of st-SCS and maybe the indication of st-SCS. Moreover, standardized training for pain physicians and basic research and clinical studies are warranted.
基金：
Guangdong provincial high-level key clinical of pain medicine; Sanming project of Shenzhen Municipal Health Commission; Shenzhen Municipal Science, Technology and Innovation Commission [SZSM202103018]; Clinical Frontier Technology Program of the First Affiliated Hospital of Jinan University [JCYJ20210324112202006]; [JNU1AF-CFTP-2022-a01212]
第一作者单位：[1]Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, Shenzhen Nanshan People’s Hospital and the 6th Aliated Hospital of Shenzhen University Health Science Center, Shenzhen, China,
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Sun Wuping,Jin Yi,Liu Hongjun,et al.Short-term spinal cord stimulation is an effective therapeutic approach for herpetic-related neuralgia-A Chinese nationwide expert consensus[J].FRONTIERS IN AGING NEUROSCIENCE.2022,14:doi:10.3389/fnagi.2022.939432.
APA：
Sun, Wuping,Jin, Yi,Liu, Hongjun,Yang, Dong,Sun, Tao...&Xiao, Lizu.(2022).Short-term spinal cord stimulation is an effective therapeutic approach for herpetic-related neuralgia-A Chinese nationwide expert consensus.FRONTIERS IN AGING NEUROSCIENCE,14,
MLA：
Sun, Wuping,et al."Short-term spinal cord stimulation is an effective therapeutic approach for herpetic-related neuralgia-A Chinese nationwide expert consensus".FRONTIERS IN AGING NEUROSCIENCE 14.(2022)
